Featured news from NHIVNA
HIV-related news from NAM
The benefit of treatment has outweighed the clinical impact of lipodystrophy, conference hears
Gus Cairns, 2016-10-26 09:00:00
The 2016 Glasgow HIV
Conference heard today that over a 20-year period, people who suffered
lipodystrophy (fat redistribution) and especially lipoatrophy (fat loss) when
they started antiretroviral therapy (ART) actually had better health outcomes
than people who did not suffer from it.
The finding, which was contrary to researchers’
expectations, shows that even if lipoatrophy exacted a social and psychological
price, because it was a marker for good adherence to HIV treatment, people who
developed it had a lower risk of death, AIDS or certain co-morbidities over the
next 20 years.